Healthcare >> CEO Interviews >> July 8, 2002
S. DAVID HILLSON has been Boston Life Sciences, Inc.'s President and
Chief Executive Officer and a member of the Board since November 1994,
and Chairman of the Board of Directors since September 1996. Prior to
his responsibilities at BLSI, Mr. Hillson was Senior Vice President of
Josephthal, Lyon & Ross, Inc., in the research and investment banking
divisions from January to November 1994, and was the Senior Managing
Director of Investment Banking at The Stamford Company from November
1992 to January 1994. Mr. Hillson was an Executive Vice President of the
asset management division of Mabon Securities from October 1990 until
October 1992. Earlier in his 15-year career as an investment manager,
Mr. Hillson was a Senior Vice President with Shearson, Lehman, Hutton
from 1983 to 1990, where he managed three mutual funds, primarily in the
emerging growth area, for the SLH Asset Management division. Prior to
his fund management responsibilities, he was the Chairman of the Equity
Committee for Hutton Investment Management from 1976 to 1982. He began
his business career as an attorney in New York City, having received his
Juris Doctorate from New York University School of Law. He also attended
the Columbia University School of Business Administration and received a
Bachelor of Arts degree from Columbia College. Profile
this company, as you look ahead 12 months?
Mr. Hillson: We have concentrated on moving into the clinic as quickly
as
